1.

2.

3.

4.

Ingredients companies - clinical data

A) What are the main scientific gaps that still exist in PET supplement development compared to human dietary supplements?

B) How important is species-specific research when selecting and developing active ingredients for pets? Can human data ever be sufficient?

C) Is the humanization of pets helping consumers make better-informed choices, or does it risk creating unrealistic expectations about supplement performance?

D) From an ingredient supplier’s perspective, which quality parameters (standardization, bioavailability, purity) are most critical for PET applications?

E) How are trends such as “clean label,” sustainability, and transparency influencing pet owners’ purchasing decisions in the PET supplement space?

F) What type of clinical evidence should realistically be expected to support PET supplement claims today?

G) Which types of claims are most likely to be misunderstood by consumers, and how can this risk be reduced through clearer substantiation and labeling?

H) What are the main methodological challenges in conducting clinical trials for companion animals, and how can they be addressed?

I) How reliable are owner-reported outcomes compared to veterinary assessments, and how should they be integrated into study design?

L) Have you noticed an increasing trend in the use of one (or more) ingredients for pet supplements formulated to promote healthy ageing?

Formulation

A) What are the biggest formulation challenges in PET supplements, particularly regarding palatability, stability, and dosing accuracy?

B) How do formulation choices (e.g., chews, powders, liquids) influence compliance and consistent use from a consumer perspective?

C) Do you see a shift toward simpler, single-ingredient formulations, or are multi-active blends still the dominant approach? Why?

D) How do species differences (dogs vs cats, size, age) influence formulation strategies?

E) Omega 3 alternatives for pet nutrition and sustainability: how do the innovative omega-3s for pet food stack up against their traditional fishy counterparts?

Regulation

A) How do regulatory frameworks for PET supplements differ between the EU and the US, and what challenges do these differences create for global brands?

B) Which types of claims represent the highest regulatory risk today, and which are more likely to be acceptable if properly substantiated?

C) Do you expect regulatory oversight of PET supplements to become stricter in the coming years? Why or why not?

D) What role should veterinarians play in guiding pet owners’ choices regarding PET supplements, and how can trust between brands, vets, and consumers be strengthened?

Open questions

A) Looking ahead 5–10 years, what will be the key factors determining the credibility and long-term success of the PET supplements sector?

B) In your view, what single change—scientific, regulatory, or educational—would most improve consumer trust in PET supplements over the next decade?